Nicholas Holzwart
0009-0008-6707-0421
1 paper found
Refreshing results…
CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study
Missing publications? Search for publications with a matching author name.